Search Results - "Jupsin, I"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Prevention of early postmenopausal bone loss by strontium ranelate: the randomized, two-year, double-masked, dose-ranging, placebo-controlled PREVOS trial by Reginster, J Y, Deroisy, R, Dougados, M, Jupsin, I, Colette, J, Roux, C

    Published in Osteoporosis international (01-12-2002)
    “…Early postmenopausal women ( n = 160) were randomised to receive placebo or strontium ranelate (SR) 125 mg/day, 500 mg/day or 1 g/day for 2 years (40…”
    Get full text
    Journal Article Web Resource
  2. 2

    Administration of a supplement containing both calcium and vitamin D is more effective than calcium alone to reduce secondary hyperparathyroidism in postmenopausal women with low 25(OH)vitamin D circulating levels by Deroisy, R, Collette, J, Albert, A, Jupsin, I, Reginster, J Y

    Published in Aging clinical and experimental research (01-02-2002)
    “…Supplementation of postmenopausal women with calcium alone or calcium-vitamin D association was suggested to have positive effects on bone turnover and bone…”
    Get full text
    Journal Article Web Resource
  3. 3

    A 5-year controlled randomized study of prevention of postmenopausal trabecular bone loss with nasal salmon calcitonin and calcium by Reginster, J Y, Meurmans, L, Deroisy, R, Jupsin, I, Biquet, I, Albert, A, Franchimont, P

    Published in European journal of clinical investigation (01-08-1994)
    “…The aim of this paper was to evaluate the long-term (5 years) efficacy of nasal salmon calcitonin in prevention of trabecular postmenopausal bone loss, which…”
    Get more information
    Journal Article
  4. 4

    Strontium ranelate: a new paradigm in the treatment of osteoporosis by Reginster, J-Y, Deroisy, R, Jupsin, I

    Published in Drugs of today (Barcelona, Spain : 1998) (01-02-2003)
    “…Not one of the currently available medications has, so far, unequivocally demonstrated its ability to fully prevent the occurrence of new vertebral or…”
    Get full text
    Journal Article Web Resource
  5. 5

    Prevention of postmenopausal bone loss by rectal calcitonin by Reginster, J Y, Jupsin, I, Deroisy, R, Biquet, I, Franchimont, N, Franchimont, P

    Published in Calcified tissue international (01-06-1995)
    “…A group (150) of healthy women, who had been menopausal for less than 5 years and who had never received any form of treatment to prevent bone loss were…”
    Get full text
    Journal Article Web Resource
  6. 6

    Long-term performance in vitro and in vivo of dual-energy X-ray absorptiometry by Reginster, J Y, Deroisy, R, Zegels, B, Jupsin, I, Albert, A, Franchimont, P

    Published in Clinical rheumatology (01-03-1995)
    “…Dual-energy X-ray absorptiometry (DXA) is actually considered as one of the most appropriate techniques for measuring bone mineral content (BMC) and bone…”
    Get full text
    Journal Article Web Resource
  7. 7

    A double-blind, placebo-controlled, dose-finding trial of intermittent nasal salmon calcitonin for prevention of postmenopausal lumbar spine bone loss by Reginster, J Y, Deroisy, R, Lecart, M P, Sarlet, N, Zegels, B, Jupsin, I, de Longueville, M, Franchimont, P

    Published in The American journal of medicine (01-05-1995)
    “…Nasal administration of salmon calcitonin (SCT) has been suggested for preventing trabecular bone loss during the first years following the menopause, but no…”
    Get more information
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15